Sarepta surges after Pfizer gene therapy data raises safety concerns
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) surged 15% on Friday after some safety concerns were raised in a small, early-stage study of a competing gene therapy for a…